Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Consensus | Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDMO | AVID BIOSERVICES INC | $781.68M | $12.66 | $31.67 | 150.13% | Buy | 4 | 34.56% | 101.56% | 70.94% | 12.78% | |
| CLNN | CLENE INC | $158.14M | $2.50 | $10.00 | 300.00% | Strong Buy | 1 | 593.79% | 48.36% | 32,584.80% | 1,231.68% | |
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $107.18M | $9.95 | $21.50 | 116.08% | Strong Buy | 1 | 89.30% | 468.60% | 100.03% | 88.11% | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.44B | $41.33 | $58.25 | 40.94% | Strong Buy | 4 | 31.43% | 65.90% | 136.26% | 62.99% | |
| GMAB | GENMAB A | $20.43B | $31.08 | $38.00 | 22.27% | Sell | 7 | 29.45% | 45.00% | 4.79% | 4.36% | |
| HALO | HALOZYME THERAPEUTICS INC | $6.11B | $44.32 | $53.00 | 19.58% | Buy | 2 | 23.83% | 9.13% | 276.16% | 61.84% | |
| TECH | BIO-TECHNE CORP | $14.37B | $366.35 | $483.75 | 32.05% | Buy | 4 | 8.78% | 20.44% | 22.11% | 16.48% | |
| CPRX | CATALYST PHARMACEUTICALS INC | $725.63M | $7.06 | $11.60 | 64.31% | Strong Buy | 5 | 17.24% | 26.36% | 42.94% | 38.29% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $8.24B | $86.18 | $113.92 | 32.18% | Buy | 12 | 16.59% | 87.84% | 49.88% | 32.36% | |
| EXEL | EXELIXIS INC | $5.70B | $17.76 | $32.67 | 83.94% | Strong Buy | 6 | 12.36% | 18.31% | 28.11% | 24.29% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $14.75B | $79.72 | $107.00 | 34.22% | Strong Buy | 7 | 19.99% | 158.02% | 18.54% | 13.43% | |
| NVO | NOVO NORDISK A S | $248.90B | $107.75 | N/A | N/A | Hold | 3 | 13.00% | 14.82% | 130.86% | 44.18% | |
| INCY | INCYTE CORP | $16.59B | $74.88 | $86.14 | 15.04% | Buy | 7 | 14.21% | 11.29% | 47.88% | 36.59% | |
| RPRX | ROYALTY PHARMA PLC | $24.00B | $39.52 | $50.00 | 26.52% | Strong Buy | 6 | 5.70% | 38.79% | 25.68% | 14.99% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $100.69M | $3.94 | $4.00 | 1.52% | Hold | 1 | 13.43% | 32.16% | -25.01% | 18.30% | |
| ABCM | ABCAM PLC | $3.32B | $14.51 | $21.00 | 44.73% | Buy | 6 | 15.50% | 188.20% | 16.65% | 11.08% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $66.14B | $258.59 | $265.25 | 2.58% | Buy | 13 | 7.18% | 14.07% | 34.47% | 26.37% | |
| CORT | CORCEPT THERAPEUTICS INC | $2.17B | $20.42 | $29.67 | 45.28% | Strong Buy | 3 | 9.29% | 6.62% | 39.08% | 34.05% | |
| VNDA | VANDA PHARMACEUTICALS INC | $560.38M | $9.92 | $12.00 | 20.97% | Hold | 1 | 0.72% | 22.28% | 7.09% | 5.90% | |
| UTHR | UNITED THERAPEUTICS CORP | $8.53B | $188.33 | $216.75 | 15.09% | Strong Buy | 5 | 8.87% | 9.78% | 25.18% | 19.62% | |
| XOMA | XOMA CORP | $209.57M | $18.35 | $49.00 | 167.03% | Buy | 3 | 8.62% | 2.19% | 25.47% | 22.39% | |
| AVIR | ATEA PHARMACEUTICALS INC | $623.60M | $7.49 | $8.00 | 6.81% | Sell | 3 | 10.62% | 3.76% | 2.45% | 2.32% |
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.